Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy - ScienceDirect
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program - ScienceDirect
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
Relative Risk Reduction Formula | Calculate RRR (with Examples)
Another Bit of Pandemic Fallout: The Weaponization of Absolute Risk Statistics - Absolutely Maybe
Muddled-up data misleads on COVID-19 vaccine efficacy - Australian Associated Press
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
VERIFY: The two ways to calculate your risk reduction by getting the COVID vaccines - YouTube
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF | JACC: Heart Failure
Article by cardiologist Aseem Malhotra made unsupported claims about the benefits and risks of COVID-19 vaccination - Health Feedback
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy - ScienceDirect
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF | Journal of the American College of Cardiology
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
Absolute Risk Reduction versus Relative Risk Reduction: Is One Better for COVID vaccines? - YouTube
Full article: Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room - The Lancet Microbe
Individual and community-level risk for COVID-19 mortality in the United States | Nature Medicine
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
VERIFY: Why is absolute risk reduction in COVID-19 vaccines smaller than relative risk reduction? - YouTube
Fact Check-Why Relative Risk Reduction, not Absolute Risk Reduction, is most often used in calculating vaccine efficacy | Reuters
Mark Murphy on Twitter: "The #Moderna #COVID19 vaccine was published on 30th December in @NEJM Improved reduction of symptomatic COVID19 Vs Pfizer/ BioNTech vaccine, therefore less people need to be vaccinated to
Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for Osteoporosis | SpringerLink
Molnupiravir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records | The BMJ
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
